BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3040031)

  • 1. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
    Erhardt K; Auer GU
    Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
    Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
    Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
    Azavedo E; Fallenius A; Svane G; Auer G
    Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contents of nuclear Feulgen-DNA in carcinoma of the breast. Cytophotometric analysis].
    Ricevuti G; Barni S
    Arch Sci Med (Torino); 1983; 140(4):393-400. PubMed ID: 6201153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary carcinoma: comparison of DNA-content in the primary tumor and the corresponding axillary lymphnode metastases.
    Erhardt K; Auer G
    Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):29-34. PubMed ID: 3962678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The DNA profile of breast cancer in situ.
    Pallis L; Skoog L; Falkmer U; Wilking N; Rutquist LE; Auer G; Cedermark B
    Eur J Surg Oncol; 1992 Apr; 18(2):108-11. PubMed ID: 1582502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
    von Rosen A; Fallenius A; Sundelin B; Auer G
    Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS; Bacus JW; Slamon DJ; Press MF
    Arch Pathol Lab Med; 1990 Feb; 114(2):164-9. PubMed ID: 1967930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
    J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.
    Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU
    Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic impact of cytochemically assessed nuclear DNA contents in human adenocarcinomas of the mammary gland.
    Askensten U
    Arch Geschwulstforsch; 1988; 58(6):431-9. PubMed ID: 3066302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of nuclear DNA in the management of cervical intraepithelial neoplasia.
    Pellicer A; Herzog RE
    Arch Gynecol; 1984; 234(3):197-204. PubMed ID: 6732289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA distributions in human normal, precancerous and cancerous breast tissue. I. Ploidy and cell cycle distribution.
    Weiss H; Kunde D; Streller B
    Arch Geschwulstforsch; 1986; 56(5):373-9. PubMed ID: 3021084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA study of vulvar intraepithelial and invasive squamous neoplasms.
    Fu YS; Reagan JW; Townsend DE; Kaufman RH; Richart RM; Wentz WB
    Obstet Gynecol; 1981 May; 57(5):643-52. PubMed ID: 7219914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluorometric grading of mammary tumors. A pilot study.
    Patek E; Johannisson E; Krauer F; Riotton G
    Anal Quant Cytol; 1980 Dec; 2(4):264-71. PubMed ID: 6258463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation of steroid receptors, tumor ploidy, and cell proliferation in various histologic types of breast cancer].
    Zubrikhina GN; Ermilova VD; Kuz'mina ZV; Bassalyk LS
    Arkh Patol; 1989; 51(3):10-6. PubMed ID: 2545183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma.
    Joensuu H; Klemi PJ
    Am J Clin Pathol; 1988 Jan; 89(1):35-40. PubMed ID: 3337050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast.
    Norris HJ; Bahr GF; Mikel UV
    Anal Quant Cytol Histol; 1988 Feb; 10(1):1-9. PubMed ID: 2833287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.